1. Effectiveness of Alpha-toxin Fab Monoclonal Antibody Therapy in Limiting the Pathology of Staphylococcus aureus Keratitis.
- Author
-
Caballero, Armando R., Foletti, Davide L., Bierdeman, Michael A., Tang, Aihua, Arana, Angela M., Hasa-Moreno, Adela, Sangalang, Emma Ruth B., and O'Callaghan, Richard J.
- Subjects
MONOCLONAL antibodies ,KERATITIS ,STAPHYLOCOCCUS aureus ,TOXINS ,CORNEA diseases - Abstract
Purpose: To investigate the effectiveness of a high-affinity human monoclonal antibody Fab fragment to Staphylococcus aureus alpha-toxin (LTM14 Fab) as therapy for S. aureus keratitis.Methods: A single topical drop of the LTM14 Fab antibody to alpha-toxin alone, or in 0.006% benzalkonium chloride (BAK), was applied every 30 min to S. aureus-infected rabbit corneas from 9 to 14 hours post-infection. Erosions and pathology were measured at 15 h post-infection.Results: LTM14 Fab with BAK limited corneal erosions better than LTM14 Fab alone (p = 0.036), and both limited erosions compared to untreated eyes (p ≤ 0.0001). Overall pathology was similar in all groups (p ≥ 0.070), but iritis and chemosis were reduced by treatment (p ≤ 0.036).Conclusions: The high-affinity human monoclonal Fab fragment antibody (LTM14 Fab) to S. aureus alpha-toxin was effective in reducing corneal damage during S. aureus keratitis. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF